Could Eli Lilly (LLY) and Novo Nordisk (NVO) soon face competition in the weight-loss drug market? Seeking Alpha analysts weigh in on who they think will launch the next big drug.
Eli Lilly (LLY) and Novo Nordisk (NVO) now boast the largest market caps in Big Pharma. But which stock is a better investment? SA analysts weigh in on the weight-loss drugmakers.
Are Mounjaro maker Eli Lilly (LLY) and Ozempic marketer Novo Nordisk (NVO) overvalued? Seeking Alpha analysts weigh in on the weight-loss drug stocks. Read more here.
Biotech Roundtable: Who will bring the next CRISPR drug to market? (NASDAQ:CRSP) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Evolus, Inc. (EOLS) lost sharply in the morning hours Friday after its partner for Jeuveau Botox, Daewoong Pharmaceutical lost a civil lawsuit in Korea. Read the full story here.